×
News Home

Is Theralase Technologies Inc. (TLTFF) a Stock to Watch After Losing -16.67% This Week?

Tuesday, May 17, 2022 11:00 AM | InvestorsObserver Analysts
Is Theralase Technologies Inc. (TLTFF) a Stock to Watch After Losing -16.67% This Week?

Overall market sentiment has been down on Theralase Technologies Inc. (TLTFF) stock lately. TLTFF receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bearish
Theralase Technologies Inc. has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on TLTFF!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With TLTFF Stock Today?

Theralase Technologies Inc. (TLTFF) stock is trading at $0.20 as of 10:36 AM on Tuesday, May 17, a drop of -$0.02, or -7.78% from the previous closing price of $0.22. The stock has traded between $0.20 and $0.22 so far today. Volume today is low. So far 119,306 shares have traded compared to average volume of 169,272 shares. To see InvestorsObserver's Sentiment Score for Theralase Technologies Inc. click here.

More About Theralase Technologies Inc.

Theralase Technologies Inc is a clinical stage pharmaceutical company. It is dedicated to the research and development of light activated Photo Dynamic Compounds, their associated drug formulations and technology platforms intended to safely and effectively; treat various cancers, bacteria and viruses. The Cool Laser Technology division designs, develops, manufactures and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, primarily in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them. Click Here to get the full Stock Report for Theralase Technologies Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App